Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Years ago, genome sequencing was getting exponentially cheaper, and supposedly would be desktop-priced soon. Did that not happen?

I noticed companies moving into the space, like 23andme, and wondered if they might work in combination to keep consumer prices high...



> I noticed companies moving into the space, like 23andme

23andme is not doing sequencing, they're doing genotyping. And they are doing so using relatively old and well-established method; so I highly doubt they will be a force of innovation in the sector for the coming times.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: